Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomicsMartin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, 20246 Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, 20246 Hamburg, Germany; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, 20246 Hamburg, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Max Planck Institute for Metabolism Research, 50931 Cologne, North Rhine-Westphalia, Germany.
Max Planck Institute for Metabolism Research, 50931 Cologne, North Rhine-Westphalia, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Max Planck Institute for Biology of Aging, 50931 Cologne, North Rhine-Westphalia, Germany.
Max Planck Institute for Biology of Aging, 50931 Cologne, North Rhine-Westphalia, Germany.
Institute of Pathology, University Hospital of Cologne, 50937 Cologne, North Rhine-Westphalia, Germany.
Division of Nephrology and Clinical Immunology, RWTH Aachen University, 52074 Aachen, North Rhine-Westphalia, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Age-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Age-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Age-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Max Planck Institute for Metabolism Research, 50931 Cologne, North Rhine-Westphalia, Germany.
Department II of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, North Rhine-Westphalia, Germany; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, North Rhine-Westphalia, Germany.
Show others and affiliations
2026 (English)In: Cell Genomics, E-ISSN 2666-979X, Vol. 6, no 10, article id 101337Article in journal (Refereed) Published
Abstract [en]
Degenerative diseases progress through gradual cell-intrinsic damage that is difficult to resolve with bulk transcriptomics or discrete cell-state analysis. We introduce a generalizable single-cell and spatial transcriptomics framework that quantifies continuous damage trajectories in vivo using cell-type-specific scores. Applied to chronic kidney disease and metabolic dysfunction-associated steatotic liver disease, the podocyte damage score (PDS) and hepatocyte damage score (HDS) place individual podocytes and hepatocytes on a health-to-damage axis. Across mouse and human single-cell RNA sequencing (scRNA-seq), single-nucleus RNA-seq (snRNA-seq), spatial transcriptomics, proteomics, histology, and clinical datasets, PDS and HDS robustly detect disease-associated damage, align disease models as well as unperturbed cells, and reveal conserved pathways. The PDS links podocyte injury and FSGS progression to circadian gene-expression disruption. The HDS identifies a damage threshold in metabolic dysfunction-associated steatotic liver disease (MASLD)/NASH beyond which hepatocytes adopt senescent, metabolically dysfunctional states. These damage scores enable scalable mapping of degenerative disease progression and stage-specific therapeutic targets.
Place, publisher, year, edition, pages
Elsevier BV , 2026. Vol. 6, no 10, article id 101337
Keywords [en]
FSGS, MASLD, cellular damage, circadian rhythm, degenerative disease, hepatocyte, podocyte, senescence, single-cell RNA sequencing, spatial transcriptomics
National Category
Cell and Molecular Biology Gastroenterology and Hepatology Medical Genetics and Genomics
Identifiers
URN: urn:nbn:se:kth:diva-387902DOI: 10.1016/j.xgen.2026.101337PubMedID: 42624116Scopus ID: 2-s2.0-105047787633OAI: oai:DiVA.org:kth-387902DiVA, id: diva2:2099024
Note
QC 20260907
2026-09-072026-09-072026-10-16Bibliographically approved